Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of infectious diseases
3.2.1.2 Technological advancements in point of care testing devices
3.2.1.3 Growing awareness among people for point of care testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High development cost of POC tests
3.2.2.2 Concerns about accuracy and reliability
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.5.1 Core technologies
3.5.2 Adjacent technologies
3.6 Future market trends
3.7 Gap analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Kits and reagents
5.3 Instruments
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Molecular diagnostics
6.3 Lateral flow immunoassay
6.4 Agglutination test
6.5 Flow-through test/immunoconcentration assay
6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Tropical diseases
7.3 Liver diseases
7.4 Respiratory diseases
7.5 Hospital associated infections
7.6 Sexual health disorders
7.7 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic centers
8.4 Research and academic institutes
8.5 Homecare settings
8.6 Others end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 Abbott Laboratories
10.2 Becton, Dickinson and Company
10.3 Biomerieux
10.4 Bio-Rad Laboratories
10.5 Cardinal Health
10.6 Chembio Diagnostics
10.7 Danaher Corporation
10.8 F. Hoffmann-La Roche
10.9 OJ-Bio
10.10 QuidelOrtho Corporation
10.11 Siemens Healthineers
10.12 Trinity Biotech
10.13 Trivitron Healthcare
